Stockscreener 앱 받기
26.03
1.32%
0.34
시장 영업 전:
26.00
-0.03
-0.12%
전일 마감가:
$25.69
열려 있는:
$26.06
하루 거래량:
2.17M
Relative Volume:
0.61
시가총액:
$4.81B
수익:
$637.78M
순이익/손실:
$239.40M
주가수익비율:
21.86
EPS:
1.1909
순현금흐름:
$307.21M
1주 성능:
+6.51%
1개월 성능:
+15.69%
6개월 성능:
-52.05%
1년 성능:
-55.40%
1일 변동 폭
$25.75
$26.45
1주일 범위
$24.51
$26.45
52주 변동 폭
$20.55
$76.51
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
26.03 | 4.81B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
168.25 | 27.46B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
52.94 | 10.27B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
49.47 | 8.88B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
83.99 | 7.10B | 1.31B | 215.20M | 408.32M | 2.4627 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-20 | 다운그레이드 | Truist | Buy → Hold |
| 2026-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2026-02-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2026-01-20 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 개시 | RBC Capital Mkts | Outperform |
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
Pictet Asset Management Holding SA Sells 735,384 Shares of Doximity, Inc. $DOCS - MarketBeat
Earnings Preview: Doximity to Report Financial Results Post-market on May 13 - Moomoo
Why the Market Dipped But Doximity (DOCS) Gained Today - Yahoo Finance
MSN Money - MSN
DOCS (NYSE: DOCS) files Form 144 to sell 9,000 shares via option - Stock Titan
Doximity Stock Down 40% in 2026: Is the Selloff Building a Multi-Year Entry Opportunity? - TIKR.com
Doximity (DOCS) price target decreased by 31.04% to 44.25 - MSN
Harel Insurance Investments & Financial Services Ltd. Purchases 90,341 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail
Vanguard Group Inc. Buys 518,916 Shares of Doximity, Inc. $DOCS - MarketBeat
Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell - Yahoo Finance
Doximity, Inc. (DOCS) Stock Analysis: Analyst Ratings Suggest 51% Potential Upside In Healthcare Tech - DirectorsTalk Interviews
Is Doximity, Inc. (DOCS) A Good Stock To Buy Now? - Insider Monkey
Is Doximity (DOCS) a Good Stock to Buy? Bullish Thesis Breakdown - HarianBasis.co
Doximity earnings up next: Can guidance ease valuation pressure? By Investing.com - Investing.com Nigeria
Move Over Doximity — There’s a New Social Network for Doctors - MedCity News
Paul Jorgensen of Doximity Pleads Guilty in $2.5M Insider Trading Case - hannahhowell.com
Assessing Doximity (DOCS) Valuation After Recent Share Price Volatility - Yahoo Finance
JPMorgan Small Cap Equity Fund's Doximity Inc(DOCS) Holding History - GuruFocus
DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Should Doximity’s CFO Transition Before Earnings Require Action From Doximity (DOCS) Investors? - simplywall.st
Vanguard reports 6.79M Doximity shares; Schedule 13G shows 5.07% (DOCS) - Stock Titan
Doximity: Buy It As Mr. Market Is Selling It Cheap Under A Panic Attack (NYSE:DOCS) - Seeking Alpha
Doximity Stock at $25: Priced for Decline or Positioned for a Double-Digit Rebound? - TIKR.com
Is It Too Late To Consider Buying Doximity, Inc. (NYSE:DOCS)? - 富途牛牛
Doximity drops as guidance trails consensus - MSN
Doximity (DOCS) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Evercore Maintains Doximity(DOCS.US) With Hold Rating, Maintains Target Price $25 - Moomoo
Doximity, Inc. (DOCS) Stock Analysis: A Look at Its 57% Potential Upside and Strong Buy Sentiment - DirectorsTalk Interviews
Doximity CFO resigns; interim finance head continues - msn.com
Doximity reaches $31M settlement in securities litigation lawsuit - MSN
Evercore ISI Group Maintains Doximity (DOCS) Outperform Recommendation - MSN
Doximity (DOCS) stock dips while market gains: Key facts - MSN
Evercore ISI Group downgrades Doximity (DOCS) - MSN
Victory Sustainable World Fund's Doximity Inc(DOCS) Holding History - GuruFocus
Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026 - The Joplin Globe
Raymond James reiterates Strong Buy on Doximity stock amid OpenAI launch By Investing.com - Investing.com India
VY(R) JPMorgan Small Cap Core Equity Portfolio's Doximity Inc(DOCS) Holding History - GuruFocus
Raymond James reiterates Strong Buy on Doximity stock amid OpenAI launch - Investing.com Australia
Wall Street Analysts Think Doximity (DOCS) Is a Good Investment: Is It? - Yahoo Finance
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine? - TradingView
Doximity (NYSE:DOCS) Stock Rating Upgraded by Zacks Research - MarketBeat
Is Doximity (DOCS) stock stable under market conditions | Doximity posts 1.2% EPS beat, solid Q1 revenueBest Pick - Xã Thanh Hà
DOCS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Hims & Hers Builds Scalable Data-Driven Personalized Care Platform - TradingView
Truist Securities downgrades Doximity (DOCS) - MSN
Doximity (DOCS) falls more steeply than broader market: What investors need to know - MSN
Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
BofA Cuts PT on Doximity, Inc. (DOCS) to $47 From $56 - Insider Monkey
Doximity (NYSE:DOCS) Shares Gap DownTime to Sell? - MarketBeat
Doximity stock holds Strong Buy at Raymond James after CFO exit By Investing.com - Investing.com South Africa
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.29%
0.51%
자본화:
|
볼륨(24시간):